62 Investor presentation Full year 2022 Large opportunity for activating m seek treatment and increasing th Wegovy ® patient c 70% of patients new to anti- obesity medication 1 8 of patien Of the people with overweight or obesity in the U 140 million people with a BMI > 27 BMI (million of people) No obesity-related como Any obesity-related com Hereof metabolic syndr 1 Individuals without any of the following obesity related conditions: T2DM, Pre-diabetes, NASH, NAFLD, obstructive sleep apnea, os musculoskeletal pain, dyslipideamia, metabolic syndrome; 3 Metabolic syndrome defined as two or more of dyslipidaemia; hyperte Source: Novo Nordisk real world research; National Health And Examination Survey (NHANES) cycles 2015-2016 and 2017-2018
Download PDF file
